WASHINGTON (Reuters) - U.S. medical device companies are defensively trying to prove that their pricey technologies are worth it as U.S. health care costs rise and more people find themselves without health insurance.Executives attending a meeting of Advamed -- the medical device industry’s trade group on Tuesday -- accused the U.S. Medicare program of not keeping up with innovations in medical devices by skimping on reimbursements.
